Authors:
Shaw, PX
Horkko, S
Tsimikas, S
Chang, MK
Palinski, W
Silverman, GJ
Chen, PP
Witztum, JL
Citation: Px. Shaw et al., Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDLby macrophages and localizes to atherosclerotic lesions in vivo, ART THROM V, 21(8), 2001, pp. 1333-1339
Authors:
Horkko, S
Olee, T
Mo, L
Branch, W
Woods, VL
Palinski, W
Chen, PP
Witztum, JL
Citation: S. Horkko et al., Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein, CIRCULATION, 103(7), 2001, pp. 941-946
Authors:
Pratico, D
Tangirala, RK
Horkko, S
Witztum, JL
Palinski, W
FitzGerald, GA
Citation: D. Pratico et al., Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F-2 alpha-VI levels and the extent of atherosclerosis in ApoE-deficientmice: modulation by vitamin E, BLOOD, 97(2), 2001, pp. 459-464
Authors:
Gillotte, KL
Horkko, S
Witztum, JL
Steinberg, D
Citation: Kl. Gillotte et al., Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors, J LIPID RES, 41(5), 2000, pp. 824-833
Authors:
Shaw, PX
Horkko, S
Chang, MK
Curtiss, LK
Palinski, W
Silverman, GJ
Witztum, JL
Citation: Px. Shaw et al., Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity, J CLIN INV, 105(12), 2000, pp. 1731-1740
Authors:
Boullier, A
Gillotte, KL
Horkko, S
Green, SR
Friedmann, P
Dennis, EA
Witztum, JL
Steinberg, D
Quehenberger, O
Citation: A. Boullier et al., The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein, J BIOL CHEM, 275(13), 2000, pp. 9163-9169
Authors:
Lee, C
Sigari, F
Segrado, T
Horkko, S
Hama, S
Subbaiah, P
Miwa, M
Navab, M
Witztum, JL
Reaven, PD
Citation: C. Lee et al., All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified - Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase, ART THROM V, 19(6), 1999, pp. 1437-1446
Authors:
Bird, DA
Gillotte, KL
Horkko, S
Friedman, P
Dennis, EA
Witztum, JL
Steinberg, D
Citation: Da. Bird et al., Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: Implications with respect to macrophage recognition ofapoptotic cells, P NAS US, 96(11), 1999, pp. 6347-6352
Authors:
Chang, MK
Bergmark, C
Laurila, A
Horkko, S
Han, KH
Friedman, P
Dennis, EA
Witztum, JL
Citation: Mk. Chang et al., Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition, P NAS US, 96(11), 1999, pp. 6353-6358
Authors:
Horkko, S
Bird, DA
Miller, E
Itabe, H
Leitinger, N
Subbanagounder, G
Berliner, JA
Friedman, P
Dennis, EA
Curtiss, LK
Palinski, W
Witztum, JL
Citation: S. Horkko et al., Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins, J CLIN INV, 103(1), 1999, pp. 117-128
Authors:
Freigang, S
Horkko, S
Miller, E
Witztum, JL
Palinski, W
Citation: S. Freigang et al., Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes, ART THROM V, 18(12), 1998, pp. 1972-1982